ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,406,895 | -12.6% | 115,494 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $2,752,334 | +24.9% | 114,920 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $2,204,423 | +24.8% | 117,132 | +5.6% | 0.00% | 0.0% |
| Q4 2022 | $1,766,116 | -3.3% | 110,937 | -0.6% | 0.00% | 0.0% |
| Q3 2022 | $1,827,000 | +10.7% | 111,652 | -4.7% | 0.00% | 0.0% |
| Q2 2022 | $1,651,000 | -43.0% | 117,200 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $2,899,000 | +19.8% | 119,699 | +15.5% | 0.00% | 0.0% |
| Q4 2021 | $2,419,000 | +35.7% | 103,614 | -3.4% | 0.00% | 0.0% |
| Q3 2021 | $1,782,000 | -11.6% | 107,258 | +29.8% | 0.00% | 0.0% |
| Q2 2021 | $2,016,000 | -40.8% | 82,647 | -37.4% | 0.00% | 0.0% |
| Q1 2021 | $3,408,000 | -52.3% | 132,100 | -1.1% | 0.00% | -66.7% |
| Q4 2020 | $7,138,000 | +18.0% | 133,509 | -9.0% | 0.00% | 0.0% |
| Q3 2020 | $6,051,000 | -15.1% | 146,705 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $7,129,000 | +116.1% | 147,093 | +88.3% | 0.00% | +50.0% |
| Q1 2020 | $3,299,000 | +6.7% | 78,098 | +8.1% | 0.00% | +100.0% |
| Q4 2019 | $3,092,000 | +43.2% | 72,278 | +20.5% | 0.00% | 0.0% |
| Q3 2019 | $2,159,000 | +51.1% | 59,983 | +12.2% | 0.00% | 0.0% |
| Q2 2019 | $1,429,000 | -1.8% | 53,471 | -1.3% | 0.00% | 0.0% |
| Q1 2019 | $1,455,000 | +113.7% | 54,171 | +28.5% | 0.00% | 0.0% |
| Q4 2018 | $681,000 | -4.4% | 42,147 | +23.0% | 0.00% | 0.0% |
| Q3 2018 | $712,000 | +36.1% | 34,267 | 0.0% | 0.00% | – |
| Q2 2018 | $523,000 | -51.9% | 34,267 | -29.2% | 0.00% | -100.0% |
| Q1 2018 | $1,088,000 | -28.2% | 48,424 | -3.8% | 0.00% | 0.0% |
| Q4 2017 | $1,516,000 | +1.6% | 50,339 | +27.1% | 0.00% | 0.0% |
| Q3 2017 | $1,492,000 | +59.1% | 39,604 | +17.8% | 0.00% | 0.0% |
| Q2 2017 | $938,000 | -17.2% | 33,631 | +2.0% | 0.00% | 0.0% |
| Q1 2017 | $1,133,000 | +226.5% | 32,968 | +173.5% | 0.00% | – |
| Q4 2016 | $347,000 | +1.2% | 12,052 | +12.0% | 0.00% | – |
| Q3 2016 | $343,000 | +35.6% | 10,760 | +38.3% | 0.00% | – |
| Q2 2016 | $253,000 | -52.8% | 7,779 | -60.5% | 0.00% | -100.0% |
| Q1 2016 | $536,000 | -7.7% | 19,717 | +20.7% | 0.00% | 0.0% |
| Q4 2015 | $581,000 | +15.5% | 16,337 | +4.1% | 0.00% | 0.0% |
| Q3 2015 | $503,000 | -14.0% | 15,697 | +10.8% | 0.00% | 0.0% |
| Q2 2015 | $585,000 | +15.8% | 14,167 | -7.7% | 0.00% | 0.0% |
| Q1 2015 | $505,000 | +27.5% | 15,350 | +25.5% | 0.00% | – |
| Q4 2014 | $396,000 | +24.5% | 12,231 | -3.9% | 0.00% | – |
| Q3 2014 | $318,000 | – | 12,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |